Thorax 2001;56:622-627 ( August )

Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests

J K Dawson^a, H E Fewins^d, J Desmond^b, M P Lynch^a, D R Graham^c

^a Department of Rheumatology, St Helens and Knowsley Trust Hospitals, Liverpool, UK, ^b Department of Radiology, St Helens and Knowsley Trust Hospitals, ^c Department of Respiratory Medicine, St Helens and Knowsley Trust Hospitals, ^d Department of Radiology, Cardiothoracic Centre, Liverpool, UK

Correspondence to: Dr J K Dawson, Department of Rheumatology, Southport and Formby District General Hospital, Southport, Merseyside PR8 6PN, UK twodocs{at}doctors.org.uk

Received 20 September 2000; Returned to authors 1 March 2001; Revised version received 2 April 2001; Accepted for publication 17 May 2001

BACKGROUNDFibrosing alveolitis (FA) is a common and serious complication of rheumatoid arthritis (RA). Before the availability of high resolution computed tomographic (HRCT) scanning, it was difficult to diagnose accurately without recourse to biopsy. Prospective studies have reported a prevalence of interstitial lung disease (ILD) of 19-44%. The term ILD used by these authors encompasses a variety of appearances on HRCT scans. This prospective study used HRCT scanning to determine the true prevalence of FA in hospital outpatients with RA, and to study associated clinical characteristics.
METHODSOne hundred and fifty consecutive patients with RA were selected from a hospital outpatient department, irrespective of the presence or absence of chest disease. All underwent a detailed clinical assessment, chest HRCT scanning, and conventional chest radiography within 4 weeks of full pulmonary function tests.
RESULTSSeventy percent of patients were current or reformed cigarette smokers. Twenty eight (19%) had FA, most frequently of reticular pattern, and 12 of this group (43%) also had emphysematous bullae. None of the previously suggested risk factors for developing FA were confirmed. Fifty four percent of patients with HRCT evidence of FA had bilateral basal chest crackles, 82% had a reduced carbon monoxide transfer factor (TLCO), 14% had restrictive pulmonary function tests, and 14% had bilateral chest radiographic signs of FA.
CONCLUSIONSHRCT evidence of FA was present in 19% of hospital outpatients with RA. Abnormalities on chest examination or on full pulmonary function tests, even without restrictive changes or chest radiographic abnormalities, should prompt physicians to request a chest HRCT scan when investigating dyspnoea in patients with RA.


Keywords: fibrosing alveolitis; rheumatoid arthritis; high resolution computed tomography

---

© 2001 by Thorax
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Kim, E. J., Collard, H. R., King, T. E. Jr (2009). Rheumatoid Arthritis-Associated Interstitial Lung Disease: The Relevance of Histopathologic and Radiographic Pattern. Chest 136: 1397-1405 [Abstract] [Full Text]  
• Chikura, B., Lane, S., Dawson, J. K. (2009). Clinical expression of leflunomide-induced pneumonitis. Rheumatology (Oxford) 48: 1065-1068 [Abstract] [Full Text]  
• Antoniou, K. M., Margaritopoulos, G., Economidou, F., Siafakas, N. M. (2009). Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement. Eur Respir J 33: 882-896 [Abstract] [Full Text]  
• Wells, A U, Hirani, N, on behalf of the BTS Interstitial Lung Disease Gui, (2008). Interstitial lung disease guideline. Thorax 63: v1-v58 [Full Text]  
• Saketkoo, L. A., Espinoza, L. R. (2008). Rheumatoid Arthritis Interstitial Lung Disease: Mycophenolate Mofetil as an Antifibrotic and Disease-Modifying Antirheumatic Drug. Arch Intern Med 168: 1718-1719 [Full Text]  
• Gochuico, B. R., Avila, N. A., Chow, C. K., Novero, L. J., Wu, H.-P., Ren, P., MacDonald, S. D., Travis, W. D., Stylianou, M. P., Rosas, I. O. (2008). Progressive Preclinical Interstitial Lung Disease in Rheumatoid Arthritis. Arch Intern Med 168: 159-166 [Abstract] [Full Text]  
• Tzelepis, G. E., Toya, S. P., Moutsopoulos, H. M. (2008). Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J 31: 11-20 [Abstract] [Full Text]  
• Brown, K. K. (2007). Roger S. Mitchell Lecture. Rheumatoid Lung Disease. Proc Am Thorac Soc 4: 443-448 [Abstract] [Full Text]  
• Kelly, C., Hamilton, J. (2007). What kills patients with rheumatoid arthritis?. Rheumatology (Oxford) 46: 183-184 [Full Text]  
• Saravanan, V., Kelly, C. (2006). Drug-related pulmonary problems in patients with rheumatoid arthritis. Rheumatology (Oxford) 45: 787-789 [Full Text]  
• Prakash, U. B.S. (2006). Uncommon Causes of Cough: ACCP Evidence-Based Clinical Practice Guidelines. Chest 129: 206S-219S [Abstract] [Full Text]  
• Kaushik, V V, Hutchinson, D, Desmond, J, Lynch, M P, Dawson, J K (2004). Association between bronchiectasis and smoking in patients with rheumatoid arthritis. Ann Rheum Dis 63: 1001-1002 [Full Text]  
• Saravanan, V., Kelly, C. A. (2004). Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis. Rheumatology (Oxford) 43: 143-147 [Full Text]  
• Estrach, C., Abernethy, V. E., Dawson, J. K. (2004). Infections and anti-TNF therapy: strategies for screening based on clinical experience. Rheumatology (Oxford) 43: 115-116 [Full Text]  
• Provenzano, G. (2003). Chronic pulmonary toxicity of methotrexate and rheumatoid arthritis. Rheumatology (Oxford) 42: 802-803 [Full Text]  
• Saravanan, V., Kelly, C. A. (2003). Survival in fibrosing alveolitis associated with rheumatoid arthritis is better than cryptogenic fibrosing alveolitis. Rheumatology (Oxford) 42: 603-604 [Full Text]  
• Dawson, J K, Fewins, H E, Desmond, J, Lynch, M P, Graham, D R (2002). Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis 61: 517-521 [Abstract] [Full Text]  
• Saravanan, V, Kelly, C A, Dawson, J K, Desmond, J, Lynch, M P, Graham, D R (2002). Fibrosing alveolitis in patients with RA. Thorax 57: 375-376 [Full Text]  
• Provenzano, G (2002). Asymptomatic pulmonary involvement in RA. Thorax 57 : 187-188 [Full Text]